Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Insider Ownership : 9.41 % (As of May. 19, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Rock Creek Pharmaceuticals Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rock Creek Pharmaceuticals's insider ownership is 9.41%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rock Creek Pharmaceuticals's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rock Creek Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 8.33%.

Rock Creek Pharmaceuticals Insider Ownership Historical Data

The historical data trend for Rock Creek Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rock Creek Pharmaceuticals Insider Ownership Chart

Rock Creek Pharmaceuticals Historical Data

The historical data trend for Rock Creek Pharmaceuticals can be seen below:

	2018-02-28	2018-03-31	2018-04-30	2018-05-31	2018-06-30	2018-07-31	2018-08-31	2018-09-30	2018-10-31	2018-11-30
Insider Ownership	9.41	9.41	9.41	9.41	9.41	9.41	9.41	9.41	9.41	9.41

Rock Creek Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rock Creek Pharmaceuticals Inc (OTCPK:RCPIQ) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

2040 Whitfield Avenue, Suite 300, Sarasota, FL, USA, 34243

Website

http://www.rockcreekpharmaceuticals.com

Rock Creek Pharmaceuticals Inc is engaged in research, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders, utilizing its proprietary compounds. The company is focusing its drug development efforts on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its proprietary formulations of its lead compound anatabine citrate. Its objective is to develop, obtain approval for, and commercialize pharmaceutical products utilizing its anatabine-based and related compounds.

Executives

Lee M Canaan	director	20101 HOOVER RD, DETROIT MI 48205
Naomi Whittel	director	C/O STAR SCIENTIFIC, INC., 4470 COX ROAD, SUITE 110, GLEN ALLEN VA 23060
Ralph B Everett	director	1299 PENNSYLVANIA AVE NW, 10TH FL, WASHINGTON DC 20004-2400
Richard L Sharp	director	C/O CIRCUIT CITY STORES, 9950 MAYLAND DRIVE, RICHMOND VA 23233
Marc D Oken	director	C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202
Odonnell Kathleen M Tr Irrev Tr 1 Fbo Francis E Odonnell Jr	other: former 10% owner
David C Vorhoff	director	C/O STAR SCIENTIFIC, INC., 801 LIBERTY WAY, CHESTER VA 23836
Christopher G Miller	officer: Chief Financial Officer	801 LIBERTY WAY CHESTER VA 23836

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Headlines

From GuruFocus

Star Scientific Inc. (STSI) President & COO Paul L Perito buys 30,000 Shares

By GuruFocus Research GuruFocus Editor • 11-13-2009

Star Scientific Inc. (STSI) President & COO Paul L Perito buys 20,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

Star Scientific Inc. (STSI) CFO Park A Iii Dodd buys 10,000 Shares

By GuruFocus Research GuruFocus Editor • 11-18-2009